2m 2m 2m 2m 2m 2m 2m
Tvardi Therap (TVRD)
NASDAQ
$1.86$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $24.8MMarket Cap
- -93.37%1-Year Change
- BiotechnologyIndustry
Tvardi Therap (TVRD)
$1.86$0.00 (0.00%)
TVRD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.86 | ||
Change | +$0.03 (+1.64%) | ||
Open | $1.83 | ||
High | $1.93 | ||
Low | $1.82 | ||
Previous Close | $1.83 | ||
Volume | 166,830 | ||
30-Day Average Volume | 353,545 | ||
1-Week Change | -2.11% | ||
1-Month Change | -34.97% | ||
1-Year Change | -93.37% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 13.3M | ||
Total Assets | $17.5M | ||
Market Cap | $24.8M | ||
Enterprise Value | $9.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.5M | ||
Free Cash Flow | -$9.2M | ||
EBIT | -$6.4M | ||
EBITDA | -$6.3M | ||
Net Working Capital | $8.0M | ||
EPS | -$0.69 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue